anti-alpha4 beta7 [Vedolizumab] - Biosimilar Antibody
anti-alpha4 beta7 [Vedolizumab] - Biosimilar AntibodyThis is a non-therapeutic reference antibody expressed in mammalian cell line while using the same variable regions from the therapeutic antibody
This non-therapeutic biosimilar antibody is ideal for research use for cell culture, assay development, Pharmacokinetics, and Pharmacodynamics (PK/PD)
*This product is not intended for diagnostic or therapeutic use
Size |
1mg |
Product Category |
Biosimilar Antibody |
Host |
HEK293 |
Isotype |
Human IgG1-Kappa |
Clonality |
Monoclonal |
Purity |
>95% by SDS-PAGE under reducing conditions; >95% by SEC-HPLC |
Purification Method |
Protein A affinity |
Endotoxin Level |
<1 EU/mg |
Formulation |
Lyophilized in PBS buffer |
Storage/Stability |
-80°C / 3 years; -20°C / 1 year |
Shipping |
Gel Packs |